Neurology Central

Advancing cerebrospinal fluid biomarker discovery by mass spectrometry


Cerebrospinal fluid (CSF) is an important source of biomarkers of neurodegenerative diseases [1]. Reflecting biochemical processes in the brain, proteins in the CSF may reveal clues to disease mechanisms. As new disease-modifying therapies are being developed, there is an increased need for markers that enable earlier, more accurate diagnosis and provide means to monitor disease progression and response to treatment.

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.